With box warnings

Without box warnings

Branded

Generic

2 results

imjudo
(tremelimumab)
AstraZeneca Pharmaceuticals LP
Usage: IMJUDO is indicated for the treatment of adult patients with unresectable hepatocellular carcinoma in combination with durvalumab. It is also used with durvalumab and platinum-based chemotherapy for adult patients with metastatic non-small cell lung cancer who lack sensitizing EGFR mutations or ALK genomic aberrations.
yervoy
(ipilimumab)
E.R. Squibb & Sons, L.L.C.
Usage: YERVOY is indicated for treating unresectable or metastatic melanoma, adjuvant melanoma post-resection, advanced renal cell carcinoma, microsatellite instability-high colorectal cancer, hepatocellular carcinoma, metastatic non-small cell lung cancer, malignant pleural mesothelioma, and unresectable esophageal cancer, often in combination with nivolumab.

CTLA-4-directed Blocking Antibody class drugs

imjudo